Complementary and alternative medicine for the treatment of multiple sclerosis
- PMID: 20441425
- PMCID: PMC2901236
- DOI: 10.1586/eci.10.12
Complementary and alternative medicine for the treatment of multiple sclerosis
Abstract
Multiple sclerosis (MS) is a chronic disabling disease of the CNS that affects people during early adulthood. Despite several US FDA-approved medications, the treatment options in MS are limited. Many people with MS explore complementary and alternative medicine (CAM) treatments to help control their MS and treat their symptoms. Surveys suggest that up to 70% of people with MS have tried one or more CAM treatment for their MS. People with MS using CAM generally report deriving some benefit from the therapies. The CAM therapies most frequently used include diet, omega-3 fatty acids and antioxidants. There is very limited research evaluating the safety and effectiveness of CAM in MS. The most promising among CAM therapies that warrant further investigation are a low-fat diet, omega-3 fatty acids, lipoic acid and vitamin D supplementation as potential anti-inflammatory and neuroprotective agents in both relapsing and progressive forms of MS. There is very limited research evaluating the safety and effectiveness of CAM in MS. However, in recent years, the NIH and the National MS Society have been actively supporting the research in this very important area.
Figures
Similar articles
-
The role of complementary and alternative medicine in therapy of multiple sclerosis.Acta Clin Croat. 2013 Dec;52(4):464-71. Acta Clin Croat. 2013. PMID: 24696997 Review.
-
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.Exp Biol Med (Maywood). 2016 Mar;241(6):620-35. doi: 10.1177/1535370215618462. Epub 2016 Jan 18. Exp Biol Med (Maywood). 2016. PMID: 26785711 Free PMC article.
-
Complementary and alternative medicine: is there a role in multiple sclerosis?Curr Neurol Neurosci Rep. 2006 May;6(3):259-67. doi: 10.1007/s11910-006-0014-y. Curr Neurol Neurosci Rep. 2006. PMID: 16635436 Review.
-
Dietary interventions for multiple sclerosis-related outcomes.Cochrane Database Syst Rev. 2020 May 19;5(5):CD004192. doi: 10.1002/14651858.CD004192.pub4. Cochrane Database Syst Rev. 2020. PMID: 32428983 Free PMC article.
-
Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study.Neurol Neurochir Pol. 2022;56(5):428-434. doi: 10.5603/PJNNS.a2022.0059. Epub 2022 Sep 7. Neurol Neurochir Pol. 2022. PMID: 36069151
Cited by
-
Therapeutic Yoga: Symptom Management for Multiple Sclerosis.J Altern Complement Med. 2015 Nov;21(11):655-9. doi: 10.1089/acm.2015.0015. Epub 2015 Aug 13. J Altern Complement Med. 2015. PMID: 26270955 Free PMC article. Review.
-
Astaxanthin Reduces Demyelination and Oligodendrocytes Death in A Rat Model of Multiple Sclerosis.Cell J. 2021 Jan;22(4):565-571. doi: 10.22074/cellj.2021.6999. Epub 2020 Apr 22. Cell J. 2021. PMID: 32347051 Free PMC article.
-
Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.Iran J Neurol. 2014;13(1):13-8. Iran J Neurol. 2014. PMID: 24800042 Free PMC article.
-
Complementary and alternative therapies in multiple sclerosis: a systematic literature classification and analysis.Acta Neurol Belg. 2022 Apr;122(2):281-303. doi: 10.1007/s13760-021-01847-3. Epub 2022 Jan 21. Acta Neurol Belg. 2022. PMID: 35060096
-
Eating Pattern and Nutritional Risks among People with Multiple Sclerosis Following a Modified Paleolithic Diet.Nutrients. 2020 Jun 20;12(6):1844. doi: 10.3390/nu12061844. Nutrients. 2020. PMID: 32575774 Free PMC article.
References
-
- Noseworthy J, Lucchinetti C, Rodriguez M, Weinshenker B. Multiple sclerosis. N Engl J Med. 2000;343:938–952. - PubMed
-
- Bjartmar C, Wujek JR, Trapp BD. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci. 2003;206:165–171. - PubMed
-
- Prat A, Al-Asmi A, Duquette P, Antel JP. Lymphocyte migration and multiple sclerosis: relation with disease course and therapy. Ann Neurol. 1999;46:253–256. - PubMed
-
- Martino G, Hartung HP. Immunopathogenesis of multiple sclerosis: the role of T cells. Curr Opin Neurol. 1999;12:309–321. - PubMed
-
- Dietrich J, Menne C, Lauritsen JP, et al. Ligand-induced TCR down-regulation is not dependent on constitutive TCR cycling. J Immunol. 2002;168:5434–5440. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical